Sodium Phytate

植酸钠

Report date: 2022/11/05 14:07:36
NME

Base Information

Drug NameSodium Phytate
Drug Alias NameHexasodium Phytate植酸六钠肌醇六磷酸钠SNF-472
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVascular CalcificationCalciphylaxisCardiovascular Abnormalities +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanifit
China Registration ClassN/A

Develop Information

Active CompaniesSanifit Therapeutics SaVifor Pharma
Inactive CompaniesN/A
Active IndicationsCalciphylaxis
Inactive IndicationsVascular CalcificationCardiovascular AbnormalitiesCardiovascular Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A